EquiPrEP:一个实施科学协议,以促进长效注射HIV暴露前预防 (LAI-PrEP) 的公平获取和采用
Christina M Kaul1,2, Brandi E Moore3, Emma Kaplan-Lewis1
1Office of Ambulatory Care and Population Health, HIV Services, NYC Health + Hospitals, New York, New York, United States of America.
PloS one
|September 19, 2023
概括
该EquiPrEP项目旨在确保为服务不足的社区提供长期的可注射HIV暴露前预防药物 (LAI-PrEP) 的公平获得. 该倡议的重点是增加纽约市优先人口在护理中的启动和保留.
科学领域:
- 实施科学 实施科学
- 预防艾滋病毒 预防艾滋病毒
- 卫生公平性健康公平性
背景情况:
- 长效注射性艾滋病毒暴露前预防 (LAI-PrEP) 提供了一种新的艾滋病毒预防方法.
- 公平获得LAI-PrEP至关重要,特别是对于代表性不足的社区.
- 该EquiPrEP项目解决了LAI-PrEP获取和吸收的潜在差异.
研究的目的:
- 为了增加整体的LAI-PrEP启动.
- 在不成比例地受影响的群体中促进LAI-PrEP的吸收.
- 确定LAI-PrEP使用和保留障碍物和促进者的障碍.
主要方法:
- 使用以公平为导向的实施科学框架.
- 招募210名参与者接受LAI-PrEP护理一年.
- 从优先人口中招募,包括黑人/拉丁裔MSM, cisgender女性和跨性别人士.
- 使用RE-AIM和CFIR框架,调查和面试进行评估.
主要成果:
- *(结果尚未在所提供的摘要中提供) *
结论:
- 基于股权的实施策略对于LAI-PrEP的推出至关重要.
- 解决结构因素是改善边缘化群体获得和保留LAI-PrEP的关键.
相关概念视频
Dose-Response Relationship: Potency and Efficacy
4.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
Analysis of Population Pharmacokinetic Data
291
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
291
Levels of Health Promotion and Illness Prevention
12.7K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
12.7K


